Examining Participation Disparities in Cancer Clinical Trials

被引:0
作者
Moore, Ami R. [1 ]
Lewis, Taylor Hudson [2 ]
Abah, Theresa [3 ]
Celebi, Mehmet [4 ]
Amey, Foster K. [5 ]
机构
[1] Univ North Texas, Coll Hlth & Publ Serv, Publ Hlth Undergrad Program, Denton, TX USA
[2] Res Triangle Inst Int, Washington, DC USA
[3] Calif State Univ Sacramento, Dept Gerontol, Sacramento, CA USA
[4] Nicholls State Univ, Dept Social Sci, Sociol, Thibodaux, LA USA
[5] Middle Tennessee State Univ, Dept Sociol & Anthropol, Murfreesboro, TN 37132 USA
关键词
clinical trials; disparity; race; ethnicity; older adults; cancer; RANDOMIZED CONTROLLED-TRIALS; ETHNIC-MINORITY PATIENTS; HEALTH-CARE-SYSTEM; ENROLLMENT; RECRUITMENT; PREVENTION; PHYSICIAN; BARRIERS; WOMEN; PERSPECTIVES;
D O I
10.1188/23.ONF.79-89
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OBJECTIVES: To examine factors that account for disparities in cancer clinical trial participation.SAMPLE & SETTING: Pooled data from Behavioral Risk Factor Surveillance System surveys between 2010 and 2017.METHODS & VARIABLES: Univariate and binary logistic regression analyses were used to examine the associations between participation in clinical trials and demographic and health characteristics, using SAS (R) procedures to account for complex sample features.RESULTS: Univariate analyses showed that age, race, income, and self-rated health status were significantly associated with the likelihood of participating in cancer clinical trials. Binary logistic analyses showed that Black respondents who were ever diagnosed with cancer were more likely to participate in cancer clinical trials relative to White counterparts. Respondents aged 50-64 years were more likely to have participated in cancer clinical trials compared to those aged 65 years or older. However, respondents who self-rated their health as excellent or very good were less likely to participate in cancer clinical trials.IMPLICATIONS FOR NURSING: Involving properly trained nurses and nurse practitioners from diverse backgrounds in cancer clinical trials to inform people with cancer about trials and ways to reduce personal barriers will increase participation from all people, regardless of socioeconomic and demographic characteristics.
引用
收藏
页码:79 / 89
页数:11
相关论文
共 75 条
[1]  
American Cancer Society Cancer Action Network, 2018, Barriers to Patient Enrollment in Therapeutic Clinical Trials for Cancer: A Landscape Report
[2]  
[Anonymous], 2018, BEH RISK FACT SURV S
[3]  
[Anonymous], 2010, Redesigning Continuing Education in the Health Professions
[4]  
[Anonymous], 2020, 2015-2019 Drug trials snapshots summary report
[5]   Social Determinants of Health: A Framework for Studying Cancer Health Disparities and Minority Participation in Research [J].
Asare, Matthew ;
Flannery, Marie ;
Kamen, Charles .
ONCOLOGY NURSING FORUM, 2017, 44 (01) :20-23
[6]  
ational Institutes of Health Revitalization Act, 1993, NAT I HLTH REV ACT 1
[7]  
BEGG CB, 1983, CANCER-AM CANCER SOC, V52, P1760, DOI 10.1002/1097-0142(19831101)52:9<1760::AID-CNCR2820520934>3.0.CO
[8]  
2-R
[9]   ONCOLOGISTS RELUCTANCE TO ACCRUE PATIENTS ONTO CLINICAL-TRIALS - AN ILLINOIS CANCER CENTER STUDY [J].
BENSON, AB ;
PREGLER, JP ;
BEAN, JA ;
RADEMAKER, AW ;
ESHLER, B ;
ANDERSON, K .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (11) :2067-2075
[10]  
Bond Mason C, 2006, Paediatr Child Health, V11, P148